T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAND
1851
DELISTED
Sandstorm Gold
SAND
| $1.08M | ﹤0.01% |
290,121
+20,956
| +8% | +$85.2K |
|
1852
Heron Therapeutics
HRTX
$63.5M
| $1.08M | ﹤0.01% |
34,023
+25,320
| +291% | +$943K |
|
1853
CarParts.com
PRTS
$50.3M
| $1.07M | ﹤0.01% |
69,271
| – | – |
|
1854
FNB Corp
FNB
$6.88B
| $1.07M | ﹤0.01% |
83,951
+563
| +0.7% | +$7.48K |
|
1855
Halozyme
HALO
$11.4B
| $1.07M | ﹤0.01% |
58,663
-563
| -1% | -$9.86K |
|
|
ESL
1856
DELISTED
Esterline Technologies
ESL
| $1.06M | ﹤0.01% |
11,709
+66
| +0.6% | +$5.55K |
|
1857
Tenet Healthcare
THC
$21.5B
| $1.06M | ﹤0.01% |
37,295
+6,800
| +22% | +$225K |
|
|
AEL
1858
DELISTED
American Equity Investment Life Holding Company
AEL
| $1.06M | ﹤0.01% |
29,855
+28
| +0.1% | +$1.01K |
|
|
VGR
1859
DELISTED
Vector Group Ltd.
VGR
| $1.05M | ﹤0.01% |
113,292
+143
| +0.1% | +$1.56K |
|
|
QTS
1860
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.05M | ﹤0.01% |
24,591
-99
| -0.4% | -$4.32K |
|
|
BBT
1861
Beacon Financial Corp
BBT
$2.71B
| $1.04M | ﹤0.01% |
25,620
+81
| +0.3% | +$3.37K |
|
1862
Viasat
VSAT
$11.4B
| $1.04M | ﹤0.01% |
16,301
+52
| +0.3% | +$3.42K |
|
|
LMNX
1863
DELISTED
Luminex Corp
LMNX
| $1.04M | ﹤0.01% |
34,384
+8,945
| +35% | +$268K |
|
1864
Vishay Intertechnology
VSH
$5.11B
| $1.03M | ﹤0.01% |
50,860
+297
| +0.6% | +$7K |
|
|
BGG
1865
DELISTED
Briggs & Stratton Corp.
BGG
| $1.03M | ﹤0.01% |
53,844
+10
| +0% | +$189 |
|
|
EFII
1866
DELISTED
Electronics for Imaging
EFII
| $1.03M | ﹤0.01% |
30,124
-136
| -0.4% | -$4.61K |
|
|
MTOR
1867
DELISTED
MERITOR, Inc.
MTOR
| $1.02M | ﹤0.01% |
52,882
-302
| -0.6% | -$6.34K |
|
1868
Southside Bancshares
SBSI
$984M
| $1.02M | ﹤0.01% |
29,373
-304
| -1% | -$10.8K |
|
1869
Hyatt Hotels
H
$16.9B
| $1.01M | ﹤0.01% |
12,643
+24
| +0.2% | +$1.89K |
|
1870
First Bancorp
FBP
$4.49B
| $999K | ﹤0.01% |
109,804
+1,299
| +1% | +$11K |
|
|
MODV
1871
DELISTED
ModivCare
MODV
| $998K | ﹤0.01% |
14,832
+1,268
| +9% | +$88.1K |
|
1872
Albany International
AIN
$1.82B
| $997K | ﹤0.01% |
12,539
-28
| -0.2% | -$2.02K |
|
1873
Photronics
PLAB
$1.97B
| $997K | ﹤0.01% |
101,255
-19,790
| -16% | -$184K |
|
|
ARNA
1874
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $997K | ﹤0.01% |
21,655
+4,793
| +28% | +$194K |
|
1875
LXP Industrial Trust
LXP
$3.58B
| $994K | ﹤0.01% |
23,941
-63
| -0.3% | -$2.75K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.